Back to Search Start Over

HLA-DR Expression Level in CD8+ T Cells Correlates With the Severity of Children With Acute Infectious Mononucleosis

Authors :
Shiji Wu
Ting Wang
Jin Huang
Renren Ouyang
Yun Wang
Wei Wei
Minxia Zhang
Min Huang
Botao Yin
Feng Wang
Hongyan Hou
Xiwen Zhang
Guoxing Tang
Ying Luo
Yuhuan Jiang
Source :
Frontiers in Immunology, Vol 12 (2021)
Publication Year :
2021
Publisher :
Frontiers Media SA, 2021.

Abstract

BackgroundThis study aimed to assess the host immune signatures associated with EBV infection and its clinical value in indicating the severity of children with acute infectious mononucleosis (IM).MethodsTwenty-eight pediatric patients with IM aged 3–8 years were enrolled. The immune phenotypes and cytokine secretion capability of T cells were detected.ResultsThe percentages and absolute numbers of CD3+and CD8+T cells were significantly increased in IM patients compared with HCs. The percentages of Naïve CD4+and CD8+T cells were decreased but with increased percentages of memory CD4+and CD8+T subsets. Our results showed the upregulation of active marker HLA-DR, TCR-αβ, and inhibitory receptors PD-1, TIGIT in CD8+T cells from IM patients, which suggested that effective cytotoxic T cells were highly against EBV infection. However, EBV exposure impaired the cytokine (IFN-γ, IL-2, and TNF-α) secretion capability of CD4+and CD8+T cells after stimulation with PMA/ionomycinin vitro. Multivariate analysis revealed that the percentage of HLA-DR+CD8+T cells was an independent prognostic marker for IM. The percentage of HLA-DR+CD8+T cells was significantly correlated with high viral load and abnormal liver function results.ConclusionRobust expansion and upregulation of HLA-DR in CD8+T cells, accompanied with impaired cytokine secretion, were typical characteristics of children with acute IM. The percentage of HLA-DR+CD8+T cells might be used as a prominent marker not only for the early diagnosis but also for indicating the severity of IM.

Details

ISSN :
16643224
Volume :
12
Database :
OpenAIRE
Journal :
Frontiers in Immunology
Accession number :
edsair.doi.dedup.....3d18c0d8431e35fd7aafd7ea2369b3f4